The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma

Journal of Veterinary Medical Science

Volumn 69, Issue 3, 2007, Pages 271-278

  Yonemaru, Kayoko ^a   Sakai, Hiroki ^a   Murakami, Mami ^a   Kodama, Atsushi ^a   Mori, Takashi ^a   Yanai, Tokuma ^a   Maruo, Kohji ^a   Masegi, Toshiaki ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Canine hemangiosarcoma; Cyclin D1; p16; p53; Rb

Indexed keywords

CYCLIN D1; PRIMER DNA; PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; COMPARATIVE STUDY; DNA SEQUENCE; DOG; DOG DISEASE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; BASE SEQUENCE; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; DOG DISEASES; DOGS; HEMANGIOSARCOMA; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34147165061     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.69.271     Document Type: Article

References (49)

1. Aagaard, L., Lukas, J., Bartkova, S., Kjerulff, A. A., Strauss, M. and Bartek, J. 1995. Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int. J. Cancer 61: 115-120.
2. Amo, Y., Masuzawa, M., Hamada, Y., Takasu, H., Fujimura, T., Katsuoka, K. and Tamauchi, H. 2000. Serum levels of vascular endothelial growth factor in a haemangiosarcoma patient with a newly typed p53 gene point mutation. Br. J. Dermatol. 143:1118-1119.
3. Bartkova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J. and Bartek, J. 1996. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 56: 5475-5483.
4. Boivin-Angele, S., Pedron, S., Bertrand, S., Desmouliere, A., Martel-Planche, G., Lefrancois, L., Bancel, B., Trepo, C. and Marion, M. J. 2000. Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma. J. Hepatol. 33:290-300.
5. Caron de Fromentel, C. and Soussi, T. 1992. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 4: 1-15.
6. Cerilli, L. A., Swartzbaugh, J. R., Saadut, R., Marshall, C. E., Rumpel, C. A., Moskaluk, C. A. and Frierson, H. F. Jr. 1999. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum. Pathol. 30:1242-1246.
7. Cobrinik, D., Lee, M. H., Hannon, G., Mulligan, G., Bronson, R. T., Dyson, N., Harlow, E., Beach, D., Weinberg, R. A. and Jacks, T. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev. 10: 1633-1644.
8. Cui, L., Shi, Y., Qian, J., Dai, G., Wang, Y., Xia, Y., Chen, J., Song, L., Wang, S. and Wang, X. 2006. Deregulation of the p16-cyclin D1/cyclin-dependent kinase 4-retinoblastoma pathway involved in the rat bladder carcinogenesis induced by terephthalic acid-calculi. Urol Res.
9. Dickerson, E. B., Thomas, R., Fosmire, S. P., Lamerato-Kozicki, A. R., Bianco, S. R., Wojcieszyn, J. W., Breen, M., Helfand, S. C. and Modiano, J. F. 2005. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma. Vet. Pathol. 42: 618-632.
10. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A. and Cote, R. J. 1994. Accumulation of nuclear p53 and tumor progression in bladder cancer. New Engl. J. Med. 331:1259-1264.
11. Esrig, D., Spruck, C. H., 3rd, Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A. and Cote, R. J. 1993. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol. 143:1389-1397.
12. Gamblin, R. M., Sagartz, J. E. and Couto, C. G. 1997. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs. Am. J. Vet. Res. 58: 857-863.
13. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Turnout, J. M. and Jones, P. A. 1995. Meth ylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55: 4531-4535.
14. Greenblatt, M. S., Bennett, W. P., Hollstein, M. and Harris, C. C. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878.
15. Grone, A., Fonfara, S., Markus, S. and Baumgartner, W. 1999. RT-PCR amplification of various canine cytokines and so-called house-keeping genes in a species-specific macrophage cell line (DH82) and canine peripheral blood leukocytes. Zentralbl. Veterinärmed. B 46: 301-310.
16. Quo, J., Sheng, G. and Warner, B. W. 2005. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J. Biol. Chem. 280: 35992-35998.
17. Hamel, P. A., Phillips, R. A., Muncaster, M. and Gallie, B. L. 1993. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. Faseb J. 7: 846-854.
18. He, J., Olson, J. J. and James, C. D. 1995. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55: 4833-4836.
19. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D. and Baylin, S. B. 1995. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530.
20. Hollstein, M., Marion, M. J., Lehman, T., Welsh, J., Harris, C. C., Martel-Planche, G., Kusters, I. and Montesano, R. 1994. p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis 15: 1-3.
21. Ikeda, M. A., Jakoi, L. and Nevins, J. R. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. U.S.A. 93: 3215-3220.
22. Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R. and Weinstein, I. B. 1993. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. U.S.A. 90: 9026-9030.
23. Johnson, A. S., Couto, C. G. and Weghorst, C. M. 1998. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 19: 213-217.
24. Lee, M. H., Williams, B. O., Mulligan, G., Mukai, S., Bronson, R. T., Dyson, N., Harlow, E. and Jacks, T. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10:1621-1632.
25. Lee, W. H., Hollingsworth, R. E., Jr., Qian, Y. W., Chen, P. L., Hong, F. and Lee, E. Y. 1991. RB protein as a cellular "corral" for growth-promoting proteins. Cold Spring Harb. Symp. Quant. Biol. 56:211-217.
26. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
27. Levine, A. J., Chang, A., Dittmer, D., Notterman, D. A., Silver, A., Thorn, K., Welsh, D. and Wu, M. 1994. The p53 tumor suppressor gene. J. Lab. Clin. Med. 123: 817-823.
28. Levine, R. A. and Fleischli, M. A. 2000. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines. Vet. Pathol. 37: 54-61.
29. Marion, M. J. 1998. Critical genes as early warning signs: example of vinyl chloride. Toxicol. Lett. 102-103: 603-607.
30. Marion, M. J. and Boivin-Angele, S. 1999. Vinyl chloride-specific mutations in humans and animals. IARC Sci. Publ. 150: 315-324.
31. Mayr, B., Resch, S., Hepperle, S., Brem, G., Reifinger, M. and Schaffner, G. 2000. Comparative studies in the promoter and exon 1 regions of tumour suppressor p53 in several mammalian species: absence of mutations in a panel of spontaneous domestic animal tumours. J. Vet. Med. A (Physiol. Pathol. Clin. Med.) 47: 593-597.
32. Mayr, B., Zwetkoff, S., Schaffner, G. and Reifinger, M. 2002. Tumour suppressor gene p53 mutation in a case of haemangiosarcoma of a dog. Acta Vet. Hung. 50:157-160.
33. Mendoza, S., Konishi, T., Dernell, W. S., Withrow, S. J. and Miller, C. W. 1998. Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res. 18: 4449-4453.
34. Naka, N., Tomita, Y., Nakanishi, H., Araki, N., Hongyo, T., Ochi, T. and Aozasa, K. 1997. Mutations of p53 tumor-suppressor gene in angiosarcoma. Int. J. Cancer 71: 952-955.
35. Nasir, L., Rutteman, G. R., Reid, S. W., Schulze, C. and Argyle, D. J. 2001. Analysis of p53 mutational events and MDM2 amplification in canine soft-tissue sarcomas. Cancer Lett. 174: 83-89.
36. Nigg, E. A. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471-480.
37. Otterson, G. A., Khleif, S. N., Chen, W., Coxon, A. B. and Kaye, F. J. 1995. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene 11:1211-1216.
38. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. and Lowe, S. W. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
39. Soini, Y., Welsh, J. A., Ishak, K. G. and Bennett, W. P. 1995. p53 mutations in primary hepatic angiosarcomas not associated with vinyl chloride exposure. Carcinogenesis 16: 2879-2881.
40. Soussi, T., Legros, Y., Lubin, R., Dry, K. and Schlichtholz, B. 1994. Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer 57:1-9.
41. Tannapfel, A., Weihrauch, M., Benicke, M., Uhlmann, D., Hauss, J., Wrbitzky, R. and Wittekind, C. 2001. p16INK4A-alterations in primary angiosarcoma of the liver. J. Hepatol. 35: 62-67.
42. Tudek, B., Kowalczyk, P. and Ciesla, J. M. 1999. Localization of chloroacetaldehyde-induced DNA damage in human p53 gene by DNA polymerase fingerprint analysis. IARC Sci. Publ. 150: 279-293.
43. van Leeuwen, I. S., Cornelisse, C. J., Misdorp, W., Goedegebuure, S. A., Kirpensteijn, J. and Rutteman, G. R. 1997. P53 gene mutations in osteosarcomas in the dog. Cancer Lett. 111: 173-178.
44. Vogelstein, B. and Kinzler, K. W. 1992. p53 function and dysfunction. Cell 70: 523-526.
45. Walker, D. R., Bond, J. P., Tarone, R. E., Harris, C. C., Makalowski, W., Boguski, M. S. and Greenblatt, M. S. 1999. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogens 18:211-218.
46. Wang, Y. C., Lin, R. K., Tan, Y. H., Chen, J. T., Chen, C. Y. and Wang, Y. C. 2005. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. J. Clin. Oncol. 23:154-164.
47. Weinberg, R. A. 1995. The molecular basis of oncogenes and tumor suppressor genes. Ann. New York Acad. Sci. 758: 331-338.
48. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
49. Wikenheiser-Brokamp, K. A. 2006. Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol. Life Sci. 63: 767-780.